30results about How to "Satisfactory treatment" patented technology

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more intracranial (IC) stimulating electrodes in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more intracranial (IC) stimulating electrodes in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) stimulating electrodes and other actuators, in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

The present invention provides methods and systems for modulating a patient's neurological disease state. In one embodiment, the system comprises one or more sensors that sense at least one signal that comprise a characteristic that is indicative of a neurological disease state. A signal processing assembly is in communication with the one or more sensors and processes the at least one signal to estimate the neurological disease state and to generate a therapy to the patient that is based at least in part on the estimated neurological disease state. A treatment assembly is in communication with the signal processing assembly and delivers the therapy to a nervous system component of the patient.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) stimulating electrodes and other actuators, in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

The present invention provides a closed-loop system for treating neurological disorders, such as epilepsy. In one embodiment the system comprises an input assembly that is adapted to receive one or more signals from a patient that are indicative of a patient's neurological state. The input assembly processes the one or more signals to generate one or more control input signals. An output assembly receives the one or more control input signals from the input assembly and generate a neuromodulation signal that is a function of the patient's neurological state. An electrode array is configured to deliver the neuromodulation signal to a patient's peripheral nerve, such as the vagus nerve.

The present invention provides a system for providing neurological disease state information to a patient. The system comprises one or more sensors that sense at least one signal that comprise feature(s) that are indicative of a neurological disease state. A signal processing assembly is in communication with the one or more sensors and processes the at least one signal to estimate the neurological disease state. A patient interface module is in communication with the signal processing assembly and communicates with a patient an output that is indicative of the patient's estimated neurological disease state.

Systems and methods for monitoring an epilepsy disease state in a human patient are described. The system includes patient components and a supervisory module. The patient components include: an implantable electrode array for collecting neurological signals, an implantable recording electrode signal processor for processing the neurological signals collected by the electrode array, and a disease state estimator for estimating the patient's disease state. The supervisory module receives the patient's disease state from the patient components and displays a time history of the patient's disease state.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) and peripheral stimulating electrodes and other actuators, in accordance with treatment parameters. The neurological control system may directly or indirectly control a portion of the autonomic nervous system, including the sympathetic and parasympathetic nervous system. Such treatment parameters may be derived from a neural or physiological response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

Provided is a long life carbide end mill which can perform stable cutting in high-efficiency machining such as die machining and parts machining. A cutting method using such an end mill is also provided. When a certain wavy or nicked peripheral cutting edge is considered a reference peripheral cutting edge with reference phases in a pitch of the reference peripheral cutting edge, wherein the distance of each reference phase is an amount corresponding to a value obtained by dividing the pitch of the nicks or waveform of each peripheral cutting edge by the number of the cutting edges; and the phase of at least one of the remaining peripheral cutting edges is deviated in the direction of the tool axis from the corresponding reference phase by an amount corresponding to 5% or less (excluding 0%) of the pitch.

A Chinese medicine in the form of particles for treating psoriasis is prepared from 13 Chinese-medicinal materials including gypsum, rehmannia root, red peony root, scutellaria root, etc. Its preparing process is also disclosed.

The invention provides a linseed oil based external drug for infantile eczema. The linseed oil based external drug comprises a raw reagent A, a compatible reagent B and a raw reagent C, wherein the raw reagent A comprises the following component by weight: 1 part of fresh egg; the compatible reagent B comprises the following components: 8 to 13% of realgar, 8 to 12% of sulphur, 10 to 15% of dried alum, and 10 to 15% of plant soot; and the raw reagent C comprises the following component in percentage by mass based on the mass of the egg in the raw reagent A: 45 to 55% of linseed oil. The preparation method of the linseed oil based external drug comprises the following steps in sequence: grinding each component in compatible reagent B into powder; sequentially adding the powder to the raw reagent A; sealing and uniformly shaking; wrapping the egg through soil and sealing; burning the egg with the soil until carbonizing; cooling in the air; removing the soil housing; grinding the soil-removed material into fine powder; heating the raw reagent C; adding the heated raw reagent C to the fine powder under fire removing state; stirring uniformly; and cooling until reaching the room temperature, thus obtaining the linseed oil based external drug for infantile eczema. The linseed oil based external drug for infantile eczema is simple in prescription, simple and quick to manufacture, low in cost, convenient to use, free from toxic or side effect during external use, and short in cure cycle.